- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02350881
Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.
A Post-Market Observational Study to Evaluate Safety and Performance of Primus™ FGT Implant at a Minimum of 5 Years Follow-up
Foot silicone implants suffer from bad reputation on the market, due to poor results obtained with the first generations of implants. Allergies to silicone, infections due to silicone and implants breakage used to be common with previous generations of silicone implants. Publications relative to those implants showed that the survival rates after 5 years of follow-up were unsatisfactory.
Since 1998, Tornier has been selling a new generation of silicone implants made of Ultrasil™. The use of this new material in its manufacturing process together with its innovative geometry, make the Primus™ FGT a much more resistant, anatomic and long lasting implant.
The main objective of this study is to evaluate the clinical outcomes of the implantation of Primus™ FGT implant in great toe arthroplasty. The study will capture long term outcomes in terms of functional metrics from documented clinical data. Other objectives are to evaluate the outcomes in terms of radiological evaluation and of safety during all the follow-up.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is an observational post-marketing surveillance study, performed by 1 (one) investigator in 1 (one) Italian site.
- Preoperative and peroperative data were collected retrospectively.
- Postoperative data (minimum 5 years follow-up or until implant revision) were collected prospectively.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Vicenza, Italy, 36100
- Casa Di Cura Villa Berica
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patient has had a Primus™ FGT implantation for one of the following indications: hallux limitus, hallux rigidus, hallux abducto valgus associated with severe arthritis, unstable or painful joint from previous surgery on the great toe,
- patient having all necessary clinical and radiographical data available.,
- patient has been informed about this scientific study and has provided their Consent to participate.
Exclusion Criteria:
- patient does not have clinical and radiographic follow-up data available.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AOFAS Hallux-MTP-IP Score - Overall
Time Frame: mean 6.9 years follow-up (range 5.2 - 9.5)
|
AOFAS (American Orthopedic Foot and Ankle Society) Hallux-MTP-IP (Hallux-Meta-Tarso-Phalangeal-Inter-Phalangeal) score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points.
The AOFAS total score is then ranging from 0 to 100 points.
A result over 80 points is considered "good", below 20 points as "bad".
|
mean 6.9 years follow-up (range 5.2 - 9.5)
|
AOFAS Hallux-MTP-IP - PAIN Score
Time Frame: mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Pain is a sub-score of the AOFAS Hallux-MTP-IP score and is measured on a scale of 40 points - the higher value represents a minimal pain.
|
mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Pain at Passive Motion of MTP1
Time Frame: mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Number of patients reporting pain at passive motion of MTP1 at preoperative and postoperative visits.
|
mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Pain at Pressure of MTP1
Time Frame: mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Number of patients reporting pain at pressure of MTP1 at preoperative and postoperative visits.
|
mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Walking Perimeter
Time Frame: mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Subjective evaluation by the patients of their walking perimeter, postoperatively versus preoperatively.
Patient had to choose among 3 variables : "improved", "same", "worsened".
|
mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Pain During Walking
Time Frame: mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Subjective evaluation by patients about pain during walking, postoperatively versus preoperatively.
Patients had to choose among 4 variables : "disappeared", "less", same", "greater".
|
mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Pain at Rest
Time Frame: mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Subjective evaluation of patients about ther pain at rest, postoperatively versus preoperatively.
Patients had to choose among 4 variables : "disappeared", "less", "same, "greater".
|
mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Osteolysis
Time Frame: mean 6.9 years (range, 5.5 - 9.5)
|
Osteolysis evaluation was described as : absent or present.
Radiological evaluations were done from available frontal and lateral view X-rays.
|
mean 6.9 years (range, 5.5 - 9.5)
|
Bone Resorption
Time Frame: mean 6.9 years (range, 5.5 - 9.5)
|
Bone resorption evaluation was described as : absent or present.
Radiological evaluations were performed from available frontal and lateral view X-rays.
|
mean 6.9 years (range, 5.5 - 9.5)
|
Survival of the Implant.
Time Frame: mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
The survival of the implant is evaluated according to the number of implant revisions or of reoperations, whatever the reason.
|
mean follow-up of 6.9 years (range, 5.2 - 9.5)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stefano FIESCHI, MD, Casa di Cura Villa Berica - Vicenza - Italy
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1202-T-FGTI-M
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Sanford HealthActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
University of EdinburghHospital for Special Surgery, New YorkRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Ottawa Hospital Research InstituteNot yet recruitingKnee Osteoarthritis | Hip Osteoarthritis
-
University Hospital, LilleCompleted
-
Massachusetts General HospitalNewton-Wellesley Hospital; The New England Baptist HospitalCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States